ما هو علاج الكيس العظمي الكبير؟ بروتوكول الخط الأول

References

DOI: 10.7759/cureus.53587

• Polidocanol sclerotherapy, on the other hand, is an appropriate first-line therapy.
• Percutaneous sclerotherapy has emerged as an excellent approach to treating ABCs in recent years.
• Polidocanol is a safe and effective sclerotherapy for ABCs, with few side effects.
• The procedure does require technical expertise with local/general anesthesia and is done under fluoroscopic guidance with added radiation exposure.
• Rastogi et al. reported a clinical response of 84.5% of 72 patients, with an average follow-up of 34 months and three injections given to each patient on average.
• Sclerosants cause damage to the vascular endothelium, promote thrombosis in small blood vessels, and trigger a series of intricate processes that culminate in the repair of the lesion.